Provided by Tiger Trade Technology Pte. Ltd.

Arm Holdings PLC ADRhedged

10.12
-0.3264-3.12%
Post-market: 10.12-0.0036-0.04%16:10 EDT
Volume:9K
Turnover:93.28K
Market Cap:4.45M
PE:- -
High:10.62
Open:10.49
Low:10.12
Close:10.45
52wk High:19.06
52wk Low:4.29
Shares:440.01K
Float Shares:440.01K
Volume Ratio:0.89
T/O Rate:2.08%
Dividend:0.16
Dividend Rate:1.55%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)

TIPRANKS
·
Aug 15

New York Closing Stocks

Dow Jones
·
Aug 15

Jianzhi Education Technology Launches $5.4 Million ADS Offering to Bolster Operations

TIPRANKS
·
Aug 14

Inside ARMH, STHH and ASMH: Three Semiconductor ADRhedged™ ETFs, and What the Currency Hedge Actually Added

TIPRANKS
·
Aug 14

Mizuho Securities Remains a Buy on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 14

Anheuser-Busch InBev S.A. ADR Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 14

Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast

TIPRANKS
·
Aug 13

Copel Board Approves R$706 Million Interest on Equity and 2025 Form 20-F Filing

TIPRANKS
·
Aug 13

Asian Companies Raise $28 Billion via ADRs in 2024, Marking a Six-Year High, as AI Boom and Valuation Gaps Drive Listings

Stock News
·
Aug 13

Anheuser-Busch InBev S.A. ADR Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

New York Closing Stocks

Dow Jones
·
Aug 13

Stocks Ex-Dividend August 14

Dow Jones
·
Aug 13

Haleon’s New Gum‑Health Toothpaste Trial: What Investors Should Watch

TIPRANKS
·
Aug 13

Cantor Fitzgerald Reaffirms Their Buy Rating on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 12

Kaspi.kz Posts Strong H1 2026 Revenue Growth as Costs Hold Profit Flat

TIPRANKS
·
Aug 12

Yi Chen Raises Approval Odds and Lifts Tinlarebant-Focused 12‑Month Price Target to $214 While Reiterating Buy Rating

TIPRANKS
·
Aug 12

NYSE Net Change Percentage Gainers & Losers

Dow Jones
·
Aug 12

NYSE Most Active Issues

Dow Jones
·
Aug 12

Anheuser-Busch InBev S.A. ADR Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease

TIPRANKS
·
Aug 12